AssetMark Inc’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-327
Closed -$12K 1494
2020
Q1
$12K Sell
327
-150
-31% -$8.53K ﹤0.01% 965
2019
Q4
$34K Sell
477
-119
-20% -$8.63K ﹤0.01% 824
2019
Q3
$45K Hold
596
﹤0.01% 745
2019
Q2
$48K Hold
596
﹤0.01% 708
2019
Q1
$40K Buy
596
+102
+21% +$7.72K ﹤0.01% 743
2018
Q4
$37K Buy
494
+28
+6% +$2.31K ﹤0.01% 757
2018
Q3
$43K Hold
466
﹤0.01% 778
2018
Q2
$46K Hold
466
﹤0.01% 739
2018
Q1
$52K Sell
466
-12
-3% -$1.34K ﹤0.01% 720
2017
Q4
$49K Buy
478
+12
+3% +$1.2K ﹤0.01% 795
2017
Q3
$44K Sell
466
-31,707
-99% -$2.5M ﹤0.01% 738
2017
Q2
$2.51M Sell
32,173
-885
-3% -$66.5K 0.03% 234
2017
Q1
$2.65M Sell
33,058
-3,497
-10% -$278K 0.03% 228
2016
Q4
$2.88M Sell
36,555
-1,911
-5% -$148K 0.04% 204
2016
Q3
$3M Buy
38,466
+37,991
+7,998% +$2.76M 0.05% 193
2016
Q2
$33K Hold
475
﹤0.01% 722
2016
Q1
$34K Hold
475
﹤0.01% 658
2015
Q4
$30K Buy
+475
New +$29K ﹤0.01% 728

Other funds holding CMD

AssetMark Inc's CMD Position: Q2 2020 in Review

AssetMark Inc sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 327 shares — an estimated $12K sold.

AssetMark Inc first reported a position in CMD in Q4 2015 and held it in 18 quarters. The position peaked at $3M in Q3 2016. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • AssetMark Inc reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • AssetMark Inc sold 327 Cantel Medical Corporation shares in Q2 2020, an estimated $12K.
  • AssetMark Inc first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 18 quarters.
  • AssetMark Inc's Cantel Medical Corporation position peaked at $3M in Q3 2016.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on AssetMark Inc's 13F filing for Q2 2020, filed 11 Aug 2020.